ANSI Anti-Trust Policy:  Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Meeting Details

Date: March 3, 2023

Time: 1PM ET

Coordinates:  Join Zoom meeting: | Meeting ID: 510 046 7805 | +1 929-436-2866-US (New York)

Attendees: Ralf Herzog (Roche), JD Nolen (Children’s Mercy Hospital), Rob Hausam (Hausam Consulting), Kathy Walsh (Labcorp, Riki Merrick (Vernetzt / APHL), Andrea Pitkus (UW), Yanick Gaudet (Global Star)

Co-chair: JD Nolen

Scribe: Riki Merrick

  • Quorum (Co-Chair + 2) Met 


  • Discussion Topics 
  • JIRAs Triage
  • Other?

Meeting Resources

JIRA Dashboards:

Meeting Minutes

Discussion Topics

  • GTIN topic
    • on agenda for this week’s main call / maybe also slot for WGM?
  • WGM schedule for specimen topics
    • Tues Q1 – should keep open for keynote
    • Add to the joint with CG Wed Q3
  • Discuss LIVD topics for this time slot
    • Maybe focus on LIVD for April and try to get it done
    • Should we add valueset for specimen now?
    • Riki will check with Ed and Hans, if this would work
      • Ed can do 4/10 and 4/24

JIRA Triage

  • V2 OO/Specimen
    • None
  • FHIR Specimen JIRAs
    • FHIR-40646
      • Example binding – if we have this value set further fleshed out, then maybe it would be good to add and increase binding to preferred
      • Reviewing the method codes based on SNOMED CT =
        • Several terms are not processing, but findings
        • How would you decide how to come up with the list of methods
          • Survey different lab domains for the methods used
            • Review SOPs in the different lab domains
          • Is there a list in DICOM?
          • Review LOINC methods
            • Cannot collect serum without processing, so method is often hidden in the LOINC method
            • Or the type of stain used
          • Ask IVD vendors for their methods / maybe FDA has some of those
        • Should “processing” be in the specimen resource, shouldn’t this be a task?
          • Yes, if you tell someone to do that
          • Maybe an event
      • IHE LDA profile could give you the information from a process perspective, but does not have the vocabulary
      • Specimen Processing Method Code Review:
      • Look at the collection terms that are included before specimen arrives in the lab
        • Categorize if these are done pre-lab and or in-lab
      • Review as homework, add comments and fill in the additional columns
      • Remove all the examination terms and their descendants - will have to see how to propose to SNOMED once review is complete
    • No other tracker in Specimen backlog

From Chat

<add chat here>

Call Adjourned at 2:58 PM EDT

Next Meeting:  

Next Time: 

<Add any overflow items here>